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Parkinson disease (PD) is a chronic neuro-
degenerative condition afflicting nearly one
million people in the United States alone
(McDonald et al. 2003). First described almost
200 years ago (Parkinson 1817), it is character-
ized clinically by resting tremor, rigidity, aki-
nesia, and bradykinesia with a subsequent loss
of postural stability. The sporadic form of the
disease typically begins after 60 years of age.
The basis for this movement disorder is a pro-
gressive loss of dopaminergic (DA) cells in the
substantia nigra pars compacta, the neurons of
the nigrostriatal DA system. The consequence
is a loss of DA in the nigrostriatal system and
thereby its control over motor function.
Symptoms become evident after the loss of
approximately 80% of these DA neurons.
Characteristic of the accompanying pathology
is the presence of Lewy bodies, which are intra-
cytoplasmic inclusions containing neurofila-
ment proteins and others such as α-synuclein
and parkin. PD brings with it an extensive
emotional and financial toll not only on the
individuals affected but also on their families
and the community. The disease is primarily
idiopathic or sporadic; Mendelian-based
genetic mutations account for less than 5% of
the total cases of PD.
The cause(s) of PD remains unknown,
and over the years the mechanism of genetic
inheritance versus environmental exposures has
been debated. It has become increasingly clear
over the past several years, however, that mul-
tiple risk factors, both genetic and environ-
mental, can produce parkinsonism (Figure 1).
No single genetic mutation can account for
most PD, an assertion underscored by the
ﬁndings of a study by (Tanner et al. 1999) that
examined more than 19,000 pairs of white
male twins from the World War II veterans
registry. The results showed no difference
in concordance rates for PD in monozygotic
and dizygotic twins 60 or more years of age.
Nevertheless, at the current time, at least nine
different genetic loci have been associated with
the familial form of the disease (Hardy et al.
2003). These include mutations in the genes
for α-synuclein and parkin, two of the proteins
found in Lewy bodies. In environmental expo-
sures, both pesticides and metals have been
implicated as risk factors for PD, based on
results from some epidemiologic studies (both
metals and pesticides) as well as from experi-
mental models (pesticides). A series of meta-
analyses of such studies, including 16 based on
living in rural areas, 18 for well-water drink-
ing, 11 for farming, and 14 for pesticide expo-
sures (Priyadarshi et al. 2001), concluded that
all these variables may be risk factors for the
development of PD.
Consistent with the potential for environ-
mental exposures to contribute to the etiology
of PD is the fact that the disease shows geo-
graphic variation in its mortality statistics. Such
variation has been reported in Japan (Imaizumi
1995), Canada (Imaizumi 1995; Svenson
1990; Svenson et al. 1993), and the United
States (Kurtzke and Goldberg 1988; Lanska
1997; Lilienfeld et al. 1990; Lux and Kurtzke
1987). Three studies using U.S. data show a
north-to-south gradient for age-adjusted PD
mortality. Figure 2 depicts results based on
1988 U.S. National Center for Health Statistics
data (Lanska 1997). The highest PD rates
occurred in the Northeast, Mid-Atlantic States,
the Midwest, and the Paciﬁc Coast states, with
intermediate levels in the mountain states and
in the Southwest and very low rates in the
South, particularly from Texas to Florida. This
is in contrast to other neurologic diseases:
stroke mortality rates are particularly high in
the Southeastern United States (Pickel et al.
1997), and cancers of the nervous system are
lowest in Pacific states including California,
Oregon, and Washington (Menck et al. 1998).
Also cited as evidence in support of envi-
ronmental contributions to this disease is that
PD occurs in greater frequency in industrialized
countries. The PD prevalence rate is reportedly
much lower in China than in the United States
Li et al. 1985; Tanner et al. 1987, 1989), and
even in China, PD appears to be associated
with industrial chemical exposures (Tanner
et al. 1989). A recent study examining PD
mortality and pesticide exposure in California
from 1984 through 1994 reported that mortal-
ity was increased in counties using agricultural
pesticides after controlling for age, gender, race,
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It has been hypothesized that developmental insults could contribute to Parkinson disease (PD), a
neurodegenerative disorder resulting from the loss of the dopamine neurons of the nigrostriatal
pathway. Two models of developmental pesticide exposures in mice are presented here that yield
PD phenotypes consistent with this possibility. Combined exposures to the herbicide paraquat
(PQ) and the fungicide maneb (MB), both of which adversely affect dopamine systems, adminis-
tered from postnatal days 5–19, produced selective losses of dopamine and metabolites and reduced
numbers of dopamine neurons in the substantia nigra. Effects were greater than those produced by
adult-only exposures. Moreover, developmental PQ + MB exposures enhanced vulnerability to this
pesticide regimen when administered subsequently in adulthood. In a second model, exposure to
MB from gestational days 10–17 markedly increased vulnerability to PQ exposures during adult-
hood, with reductions in dopamine and metabolites and numbers of dopamine neurons in the sub-
stantia nigra. Females evidenced protection in both models. Collectively, these models demonstrate
that developmental exposures can produce progressive, permanent, and cumulative neurotoxicity of
the nigrostriatal dopamine system and enhance vulnerability to subsequent environmental insults.
Finally, effects of PQ + MB were greater than those of either pesticide alone in the postnatal model.
This is consistent with a multiple-hit hypothesis predicting that multiple concurrent insults occur-
ring at different target sites within a system (here nigrostriatal dopamine) may constrict the range
and ﬂexibility of compensatory mechanisms, thereby compromising the integrity and viability of
the system. As such, this hypothesis presents a biologic strategy for identifying potentially signiﬁ-
cant neurotoxic mixtures for hazard identification in future studies. Key words: development,
dopamine, maneb, nigrostriatal system, paraquat, Parkinson disease, pesticides, substantia nigra.
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and Yu 2000). The fact that the prevalence of
PD in immigrant populations is comparable to
the prevalence rate in the country of destination
is also indicative of an environmental exposure
basis of PD. For example, the prevalence of PD
in Nigeria is lower than that for U.S. African
Americans (Schoenberg et al. 1988); those of
African Americans and whites in the United
States are reported to be similar (Schoenberg
et al. 1985), even though the African popula-
tions in the United States and Nigeria are
largely homogeneous genetically after control-
ling for age and other variables that likely differ
between countries. Similarly, Americans of
Japanese or Okinawan ancestry have been
reported to exhibit a PD incidence similar to
that of white Americans, which is higher than
that in Asian countries (Morens et al. 1996).
This apparent multiplicity of risk factors
supports a growing belief that PD may be
multifactorial in nature rather than a disease
that can be ascribed to a unitary etiology. PD
may be the result of the net interactions of
multiple risk factors encountered over the life-
time, that is, a lifelong bionetwork of inter-
actions, which in addition to those promoting
risk, would also include factors that have
shown to be protective against PD, such as
caffeine and cigarette smoking (Baron 1986;
Gorell et al. 1999; Kessler and Diamond
1971; Ross and Petrovitch 2001). Such a mul-
tifactorial etiology also would be consistent
with PD because the disease exhibits marked
heterogeneity with respect to signs and symp-
toms that manifest, the age of onset, and the
rate of progression. For such reasons, it may
be more appropriate to think of PD not as a
unitary disease entity but rather as a broader
phenotype. Such a premise may also explain
why early studies that examined the potential
for one such pesticide, paraquat (PQ), to pro-
duce parkinsonism were not particularly com-
pelling (Bagetta et al. 1992; Markey et al.
1986; Perry et al. 1986). Investigators became
interested in PQ particularly as a pesticidal
risk factor because it shares a marked struc-
tural similarity to MPP+ (1-methyl-4-
phenylpyridinium), the most widely used
experimental model of PD.
However, PQ exposure does not occur in
isolation but instead occurs in conjunction
with many other risk factors, including other
environmental chemicals. Indeed, one can con-
sider a type of multiple-hit hypothesis for the
impact of multiple risk factors targeting the
brain. Specifically, the brain may readily be
able to compensate for the effects of an indi-
vidual chemical alone acting on a particular
system of the brain. However, when multiple
target or functional sites within that particular
system are attacked by different mechanisms
(i.e., multiple chemical exposures or chemical
exposures combined with other risk factors),
the system may no longer be able to homeo-
statically reregulate itself, thereby leading to
sustained or cumulative damage. Figure 3 pro-
vides a hypothetical example featuring a DA
terminal. Four concurrent insults are por-
trayed. Although all four insults target the DA
terminal, they do so by different mechanisms,
that is, at different sites of the same system.
Here, for example, insult A targets the vesicular
monoamine transporter in which DA is stored;
insult B attacks the enzyme converting tyrosine
to DOPA (3,4-dihydroxyphenylalanine) and
thus the DA metabolic pathway; insult C strikes
the metabolism of DOPAC (3,4-dihydroxy-
phenylacetic acid) to HVA (homovanillic
acid); and insult D hits the DA transporter
that takes DA back up from the synaptic cleft
postrelease. Multiple insults occurring concur-
rently at multiple sites within the system may
constrict the range and ﬂexibility of compen-
satory mechanisms, thereby compromising the
integrity and viability of the system. As a con-
sequence, mixtures could have effects that are
more robust and more rapid in onset and that
differ in character from effects produced by
single exposures.
On the basis of such considerations, we
posited that concurrent exposures to multiple
pesticides that target the nigrostriatal DA
systems but that do so through different
mechanisms might provide more significant
neurotoxicity (Cory-Slechta, in press). Thus,
an exposure model was developed in young
adult mice based on combined exposure to the
herbicide PQ and the fungicide maneb (MB),
based on their DA effects (Bagetta et al. 1992;
Calo et al. 1990; Liou et al. 1996; Markey
et al. 1986; Miller et al. 1991; Morato et al.
1989; Perry et al. 1986; Takahashi et al. 1989;
Walters et al. 1999; Yoshimura et al. 1993).
PQ shares a remarkable structural similarity to
MPP+, the most widely used experimental
model of the PD phenotype. MB actually
enhances the effects of MPTP (1-methyl-
4-phenyl-1,2,3,6-tetrahydropyridine; parent
compound of MPP+). This model in young
adult C57Bl/6 mice was produced by admin-
istration of doses of 10 mg/kg PQ, 30 mg/kg
MB, or combined PQ + MB, intraperitoneally
(ip) twice a week for 6 weeks, for a total of
12 doses, and was shown to result in a PD
phenotype (Thiruchelvam et al. 2000a, 2000b).
In this phenotype, effects of PQ + MB were
found to be potentiated; that is, for some meas-
ures, effects of combined PQ + MB were found
where neither pesticide administered alone had
any impact. The observed effects were, more-
over, highly selective for the nigrostriatal DA
system and irreversible. Additionally, studies
using the PQ + MB model have shown a
greater vulnerability of males to the combined
treatment, which is consistent with observations
from epidemiologic studies of PD (Wooten
et al. 2004). These studies suggest that the
greater incidence of the disease reported
in males in epidemiologic studies may not only
be due to greater exposures to potential
Cory-Slechta et al.
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Figure 1. Multiple different insults lead to the PD
phenotype: schematic depicting various risk fac-
tors that have been associated either with
increased odds ratios for PD in epidemiologic stud-
ies or with producing characteristics of the pheno-
type in experimental models. Circles show genes
associated with PD, rectangles depict metals impli-
cated in PD, dotted rectangles depict pesticides
implicated as risk factors, and dashed rectangles
depict physiologic risk factors that contribute.
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Figure 2. Age-adjusted mortality data for PD for states in the United States. Based on 1988 data and
adapted from Lanska (1997).
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5.074–7.354environmental risk factors such as pesticides but
also may be related to gender-based physiologic
differences. Our studies also now indicate that
both aging (Thiruchelvam et al. 2003) and
overexpression of mutant human α-synuclein
(Thiruchelvam et al. 2004) can enhance the PD
phenotype produced by PQ + MB.
Developmental Insults 
and Parkinson Disease
Although PD is a neurodegenerative condition
with a late-life onset, the possibility that it
could be related to insults that occur early in
life has been raised. Indeed, the pattern of
manifestation of signs and symptoms should
not be presumed to coincide with the timing
of etiologic factors. Figure 4 depicts hypotheti-
cal models in which events occurring early in
life could contribute or lead to PD later in life.
Normal age-related degeneration in the DA
system has been repeatedly described, which
includes the loss of DA cell bodies as well as
alterations that compromise the function of
residual DA neurons (Anglade et al. 1997;
Cabello et al. 2002; Calne and Langston
1983; Roth and Joseph 1994). Insults during
the adult stage of the life cycle superimposed
on such normal aging could further decrease
DA function and lead more rapidly to the
symptomatic PD range (< 20%; shaded area of
Figure 4). It could be posited that events
occurring early in development have long-
term, delayed consequences for DA systems
that may become evident only as the DA sys-
tem undergoes further adult-related cell loss.
For example, a developmental insult alone
could accelerate the loss of DA neurons across
life (solid red line), such that the percentage of
DA function reaches the symptomatic PD
range more rapidly. Adult insults superim-
posed upon such an enhanced decline, more-
over, could further accelerate such a process
(dashed red line). Alternatively, or in addition
to these events, developmental insults could
result in an early loss of DA neurons such that
the entire curve of degeneration is displaced
downward (solid green line) and again the
symptomatic range is reached earlier in life,
again, with such a possibility further acceler-
ated by adult insults (dashed green line).
The potential for adverse effects of pesticide
exposures to infants and children is of signiﬁ-
cant concern (Kimmel and Makris 2001;
Mendola et al. 2002; Tilson 1998). Many pes-
ticides were speciﬁcally designed to affect the
nervous system of pests, but the phylogenetic
parsimony of nervous system structure and
function across species leaves humans at risk as
well. This must be coupled with the fact that
numerous factors contribute to the particular
vulnerability of the developing nervous system
to environmental chemical exposures. One is
the complex series of events associated with
brain development, which starts during the
embryonic period and actually extends through
adolescence. During this time, progenitor cells
in the brain must travel in a deﬁned time frame
to their appropriate location and establish func-
tional connections that are the basis for signals
that ultimately underlie complex human behav-
ior. In humans this period is primarily during
the prenatal period. An additional factor opera-
tive early in life that can contribute to enhanced
vulnerability of the brain is the incomplete
development of the blood–brain barrier,
including possible enhanced permeability to
toxicants, or other examples of altered toxico-
kinetics. Although the barriers to blood–brain
and blood–cerebrospinal ﬂuid interfaces (i.e.,
tight junctions) are present from early in devel-
opment, permeability to small lipid-insoluble
molecules is greater in developing brain, and
mechanisms of ion and amino acid transfer
develop only sequentially with brain growth
(Saunders et al. 1999).
Such possibilities raise at least three ques-
tions: a) Can developmental environmental
insults lead to progressive or permanent nigro-
striatal DA neurotoxicity? b) Will this insult
alter vulnerability to subsequent environmental
insults? c) Can such environmental insults pro-
duce cumulative neurotoxicity? The answers to
such questions were pursued using the com-
bined PQ + MB model described previously.
Subsequent studies using PQ + MB
were undertaken to address the questions
posed above with respect to exposures during
development. Findings from these efforts
attest to the signiﬁcance of early development
as a period of vulnerability for insults that later
lead to a PD phenotype, demonstrating posi-
tive answers to all three questions. Indeed,
ﬁndings from these studies also raise new and
important issues concerning the adequacy of
current risk assessment strategies.
Developmental Environmental
Insults: Dopamine Neurotoxicity
and Altered Vulnerability
Can developmental environmental insults lead
to progressive or permanent nigrostriatal DA
neurotoxicity? Will this insult alter vulnerabil-
ity to subsequent environmental insults? To
address these questions related to the potential
for developmental insults to lead to a PD phe-
notype, C57Bl/6 mice were exposed as shown
in Figure 5 to the pesticides PQ + MB alone
or in combination during postnatal days 5–19
at doses that were 1/30th of those used in the
young adult studies (Thiruchelvam et al.
2002). Locomotor activity was assessed at
6 weeks and again at 6 months of age. In our
studies, this measure has proven to be predic-
tive of underlying nigrostriatal DA neuron
loss. At 6.5–7.5 months of age, a subset of
these mice were rechallenged with the same
(adult) dosing regimen of the pesticides. Some
mice were exposed to the pesticides only as
adults. Approximately 2 weeks after the end of
the adult rechallenge, locomotor activity was
Developmental pesticide exposures and parkinsonism
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Figure 4. Hypothetical models by which insults
incurred during development with or without added
insults later in life can accelerate the onset to a PD
phenotype by reaching the point where only approx-
imately 20% of DA function remains. The solid black
line depicts the rate of normal aging of the DA sys-
tem; an adult insult superimposed upon this function
accelerates the development of the disease (dashed
black line). An insult occurring during development
(solid red line) could increase the slope of the nor-
mal decline such that the level of DA dysfunction is
reached earlier in life. An adult insult(s) superim-
posed upon this function (dashed red line) would
further accelerate the process. Another model
would involve a developmental insult that results in
a loss of DA neurons early in life (solid green line)
such that the reserve capacity is diminished and the
result is a more rapid onset of the disease, again, a
process that could be hastened by additional insults
incurred later in life (dashed green line). Modified
from Thiruchelvam et al. (2002).
Figure 3. Schematic depicting the multiple-hit
hypothesis as applied to a DA terminal within the
central nervous system. Four concurrent insults
are depicted that occur at different target sites of
the DA terminal: insult A affects the vesicular
transporter; insult B, affects the metabolism of
tyrosine to DOPA; insult C, affects the breakdown
of DOPAC; and insult D, affects the DA transporter.
The multiple-hit hypothesis here presumes that the
brain may readily be able to compensate for the
effects of an individual chemical itself acting on a
particular target system of the brain. However,
when multiple target or functional sites within that
particular system are attacked by different mecha-
nisms (i.e., multiple chemical exposures or chemi-
cal exposures combined with other risk factors),
the system may no longer be able to homeostati-
cally reregulate itself, thereby leading to sustained
or cumulative damage. Modiﬁed from Cory-Slechta
(in press).
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Extracellular DAagain evaluated, and brains were harvested
thereafter for determinations of levels of DA
and metabolites and for assessment of num-
bers of DA neurons using unbiased stereologic
determinations.
Figure 6 depicts total locomotor activity
(total horizontal activity counts across the
duration of the session) measured in 45-min
sessions at 6 weeks of age and again at
6 months of age, the latter determination
occurring more than 5 months after pesticide
exposure. Locomotor activity reductions were
seen only in the PQ + MB group and not in
response to either PQ or MB alone; that is,
effects were potentiated. Reductions of 23%
were evident in the PQ + MB group at 6 weeks
of age, and by 6 months of age levels were fur-
ther reduced by 38% relative to that of con-
trols. Thus, these effects were progressive and
could also be presumed to be permanent.
Changes in levels of DA and its metabolites
were determined in striatum at the termination
of the experiment, when mice were approxi-
mately 8–9 months of age. DA and DOPAC
(3,4-dihydroxyphenylalacetic acid) levels are
depicted in Figure 7 for groups that were
exposed only during development or only as
adults and those exposed developmentally and
rechallenged as adults (developmental + adult).
Relative to controls, developmental exposure to
PQ alone decreased levels of DA, but these
reductions were notably enhanced by combined
PQ + MB, whereas MB alone had no impact.
Similar but far less pronounced effects were
seen in mice treated only as adults, where only
PQ + MB produced significant reductions.
The most dramatic effects were observed in
groups treated developmentally and then
rechallenged as adults, where reductions
occurred in response to both PQ alone and
MB alone, with even more marked effects in
the group receiving PQ + MB, where levels of
DA were reduced by 62% relative to those of
controls. Moreover, developmental exposure
followed by adult rechallenge unmasked silent
toxicity apparently produced by MB treatment
during development: although no changes
were seen in response to developmental-only
MB exposure, reductions did occur when it
was followed by adult rechallenge with MB. A
highly similar pattern of treatment-related
effects was seen for DOPAC.
A similar but more marked profile of
effects was observed for changes in TH+ neu-
rons (Figure 8). In this case even developmen-
tal-only exposures to PQ alone and to MB
alone produced modest but statistically signiﬁ-
cant decreases in numbers of DA neurons in
the substantia nigra pars compacta, and even
larger reductions were found for combined
PQ + MB. In adult-only exposures, both PQ
alone and PQ + MB produced small but sig-
niﬁcant reductions (10–15%) in numbers of
TH+ neurons. The most dramatic effects were
again seen in groups treated developmentally
and then rechallenged as adults. Here, the
reductions produced by PQ alone and MB
alone were significantly greater than those
observed in response to developmental-only
exposures. So, too, was the reduction in the
PQ + MB group, where the TH+ neuron
count decreased approximately 67% relative to
control. These effects were not mirrored by
Cory-Slechta et al.
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Figure 5. Depiction of the experimental design for the experiment examining postnatal exposure to PQ
and/or MB in C57Bl/6 mice. PN, postnatal days. Pups were treated with saline, 0.3 mg/kg PQ, 1.0 mg/kg
MB, or the combination administered ip from PN 5–19 of gestation. Offspring were tested for locomotor
activity at 6 weeks of age and again at 6 months of age. A subset of mice were rechallenged at
6.5–7.5 months of age with saline, 10 mg/kg PQ, 30 mg/kg MB, or the combination administered twice per
week for 6 weeks, for a total of 12 doses. Another set of mice were given these treatments only as adults.
Approximately 2 weeks after the adult treatments, locomotor activity was evaluated and brains harvested
for determinations of levels of DA and metabolites and for determinations of numbers of neurons using
unbiased stereology. Modiﬁed from Thiruchelvam et al. (2002).
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Figure 7. Levels of DA (A) and the metabolite DOPAC (B) measured at 2 weeks after adult rechallenge in
mice exposed developmentally only to saline (Sal) or to 0.3 mg/kg PQ, 1.0 mg/kg MB, or the combination
via ip administration postnatally (Developmental); developmentally followed by adult rechallenge with
saline, 10 mg/kg PQ, 30 mg/kg MB, or the combination administered twice per week for 6 weeks for a total
of 12 doses (Developmental + Adult); or only as adults to saline, 10 mg/kg PQ, 30 mg/kg MB, or the combi-
nation administered twice per week for 6 weeks for a total of 12 doses (Adult), as shown in Figure 5.
Modiﬁed from Thiruchelvam et al. (2002). 
Significant differences were found compared with acorresponding saline; bcorresponding adult only; ccorresponding
developmental only; dMB alone; eand PQ alone. 
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Figure 6. Locomotor activity changes after postnatal
exposure: total locomotor activity counts in 45 min
sessions measured at 6 weeks of age and again at
6 months of age in mice exposed developmentally to
saline, 0.3 mg/kg PQ, 1.0 mg/kg MB, or the combina-
tion via ip administration postnatally as shown in
Figure 5. Modiﬁed from Thiruchelvam et al. (2002).
Signiﬁcant differences were found compared with acorre-
sponding saline control; bcorresponding PQ group; and
ccorresponding MB alone.changes in numbers of TH– neurons in the
nigra (not shown) or by reductions in TH+
neurons in the ventral tegmental area (region
of cell bodies for the mesolimbic DA system;
not shown); that is, these reductions were
highly selective for the nigrostriatal DA system.
The protection of females from the effects
of PQ + MB was particularly striking. For
example, Figure 9 displays the changes in stri-
atal levels of DA presented for males in
Figure 6 and corresponding data for females.
The reductions in DA levels produced by vir-
tually all treatments were either attenuated or
absent in females, with the exception of the
reduction in DA in response to developmental
exposure to PQ alone. The most obvious pro-
tection can be seen in comparing males with
females in the groups exposed developmentally
and rechallenged as adults. In these groups,
females did show some reductions in levels of
DA relative to those of their control group, but
the magnitude of the effect was markedly
reduced relative to the corresponding reduc-
tions observed in males.
This protection in females likewise
extended to the reduction in numbers of TH+
neurons in the substantia nigra pars compacta
produced by these pesticide exposures, as
shown in Figure 10. Figure 10 shows that the
reductions produced by adult exposures, and
particularly by developmental exposures fol-
lowed by adult rechallenge were signiﬁcantly
reduced in females compared with males. The
reductions produced in response to develop-
mental-only exposures were, however, of gen-
erally comparable magnitude in the two
genders, suggesting a postpubertal change.
Collectively, these ﬁndings showing that pro-
tection in females is conferred postpuberty
suggests that events associated with matura-
tion of reproductive systems may play a role in
this response.
It is important to note that the effects
described in response to these treatments
were seen in the absence of any indications of
systemic toxicity in treated mice, including
the lack of any weight loss; indeed, mice
gained weight across the experiment. Nor
were any gross histopathologic changes
found. Thus, the effects observed are not
a reflection in any sense of a generalized
toxicity.
Developmental pesticide exposures and parkinsonism
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Figure 8. Total numbers of TH+ neurons in the sub-
stantia nigra pars compacta measured using un-
biased stereology at 2 weeks after adult rechallenge
in mice exposed as described in Figure 7. Sal, saline.
Modiﬁed from Thiruchelvam et al. (2002).
Signiﬁcant differences were found compared with acorre-
sponding saline; bcorresponding adult only; ccorrespond-
ing developmental only; dMB alone; ePQ alone.
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Can Such Environmental
Insults Produce Cumulative
Neurotoxicity?
Human exposures occur to mixtures over the
life span, with the speciﬁc components of that
mixture no doubt changing across time. One
question raised by such exposure scenarios is
whether sequential exposures across the life-
time would result in cumulative neurotoxicity
to the nigrostriatal DA system. This too can
be posited in the context of the multiple-hit
hypothesis described previously, in that
sequential and permanent damage to different
target sites within the system could also result
in compromise of homeostatic regulatory
capacities. This question was pursued using
the experimental design depicted in Figure 11.
In this study C57Bl/6 mice were exposed
during gestation to saline or to MB only via
administration to the dam of a dose of
1 mg/kg (1/10th the dose used in young adult
studies) subcutaneously (sc) during gesta-
tional days 10–17, a time frame chosen to
correspond to the emergence of the nigrostri-
atal DA system. Pups were weaned at 25 days
of age, and locomotor activity was evaluated
at 6 weeks of age, again as a preliminary gauge
of underlying changes in the DA system. At
approximately 2 months of age, a subset of
mice was challenged with saline, with
5 mg/kg PQ alone, or with 30 mg/kg MB
alone, the doses used with young adult mice,
and these doses were administered daily for
8 days. One week later, locomotor activity
was redetermined, and brains were harvested
for determinations of levels of catecholamines
and stereologic assessment of numbers of DA
neurons (Barlow et al. 2004).
Findings from this study were largely
unexpected. Changes in locomotor activity
measured 7 days after the adult rechallenge
are shown in Figure 12 for both males and
females treated developmentally with saline or
MB and rechallenged as adults with saline,
PQ alone, or MB alone. With this particular
exposure regimen, prenatal exposure to MB
alone followed by adult rechallenge with PQ
alone produced dramatic reductions in loco-
motor activity at this time point, effects that
were seen only in males. Correspondingly, the
reductions in levels of DA and of its metabo-
lite DOPAC that were observed occurred
only in response to prenatal MB exposure fol-
lowed by adult rechallenge with PQ alone
(Figure 13) and, again, in males but not in
females. In addition, this regimen, that is,
prenatal MB followed by adult rechallenge
with PQ, produced a loss of TH+ neurons
that occurred selectively in the substantia
nigra pars compacta and not in the ventral
tegmental area (compare Figure 13A,B). Also,
there were no changes in numbers of TH–
neurons. Furthermore, females were protected
from this loss of TH+ substantia nigra neu-
rons (Figure 14) as they were from the other
adverse effects of prenatal MB followed by
adult PQ exposure. As in the previous study
(Thiruchelvam et al. 2002), these effects were
seen in the absence of any indication of sys-
temic toxicity, body weight loss, or gross
histopathology.
Conclusions and Research
Needs
These studies demonstrate the ﬁrst examples of
models of the PD phenotype based on develop-
mental pesticide exposure. Our ﬁndings con-
firm that a developmental insult can have
effects that appear to be progressive and perma-
nent and ultimately lead to damage to the
nigrostriatal DA system, including loss of TH+
neurons (Figures 10, 14), consistent with the
hypothetical models posed in Figure 4. In addi-
tion, both the postnatal and gestational expo-
sure experimental models examined here
Figure 14. Numbers of TH+ and TH– neurons in the substantia nigra pars compacta (A) and ventral striatum
(B) measured using unbiased stereology 7 days after the last adult rechallenge with saline, 5 mg/kg PQ, or
15 mg/kg MB administered ip every day for 8 days after prenatal exposure to either saline or 1.0 mg/kg MB
administered sc during gestational days 10–17 as shown in Figure 11. Values are shown for both male and
female offspring. Modiﬁed from Barlow et al. (2004).
Signiﬁcant differences were found compared with asame-gender Sal–Sal; bsame-gender MB–Sal; csame-gender Sal–PQ;
and dopposite-gender same-exposure condition. 
Figure 13. Levels of (A) DA and its metabolites (B) DOPAC and (C) HVA measured by HPLC 7 days after the last adult rechallenge with saline, 5 mg/kg PQ, or
15 mg/kg MB administered ip every day for 8 days after prenatal exposure to either saline or 1.0 mg/kg MB administered sc during gestational days 10–17 as
shown in Figure 11. Sal, saline. Values are shown for both male and female offspring. Modiﬁed from Barlow et al. (2004)
aSigniﬁcantly different from same-gender saline–saline, same-gender MB–saline, and same-gender PQ–saline.
Figure 12. Total locomotor activity counts meas-
ured in 45 min sessions 7 days after the last adult
rechallenge as described in Figure 11. Sal, saline.
Values are shown for both male and female off-
spring. Modiﬁed from Barlow et al. (2004).
aSigniﬁcantly different from all other comparisons.
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Males Femalesshowed that pesticide exposures during devel-
opment increased vulnerability to subsequent
pesticide exposures occurring later in life.
These ﬁndings indicate that vulnerability can
accumulate across insults, such that the effects
of successive insults may actually be enhanced.
Indeed, repeated insults also revealed underly-
ing silent toxicity, wherein effects of develop-
mental exposures to pesticides alone manifested
only after adult rechallenge with the same or
even a different pesticide. These ﬁndings also
underscore the need for inclusion of childhood
pesticide exposures in epidemiologic studies
and further evaluation in experimental models.
The basis for the protection observed in
females in these studies, mainly conferred post-
pubertally, is not yet clear. In addition to gen-
der-related differences in time to onset of,
magnitude of effects of and, perhaps, incidence
that are reported in diseases and dysfunctions in
which DA systems play a key role (e.g., atten-
tion deﬁcit hyperactivity disorder, schizophre-
nia, PD), experimental studies have repeatedly
demonstrated protective effects of estrogen in
various experimental models, including protec-
tion against the DA toxicity associated with the
experimental compound MPTP as well as
against methamphetamine-induced DA toxicity
(Dluzen and McDermott 2002; Dluzen et al.
1996; Miller et al. 1998). The mechanism(s) of
such effects remains unknown and may be
diverse but could include effects on DA release,
on the DA transporter, and/or on the activity of
tyrosine hydroxylase (TH), the rate-limiting
enzyme in the DA synthesis pathway (Dluzen
and McDermott 2000; Kuppers et al. 2000).
This is a finding clearly warranting further
experimental attention given the potential for
therapeutic considerations.
One unexpected ﬁnding from these stud-
ies was the dramatic enhancement of the
nigrostriatal dopaminergic toxicity associated
with PQ treatment when it was administered
in adulthood after developmental exposure to
MB. The mechanisms responsible for this
enhancement of toxicity, particularly given
the time lag between treatments (~ 10 weeks),
is not yet known. In adults the effects of PQ
are potentiated by MB at least partly through
a toxicokinetic interaction in which the levels
of PQ in brain are increased and the rate of
elimination from brain is decreased by co-
administration with MB, effects that may be
related to an inhibition of efﬂux transport of
PQ by MB (Barlow et al. 2003). Clearly, such
a mechanism cannot be operative in the cur-
rent experiment using gestational MB fol-
lowed by adult PQ given the time lag
between exposures. Little is known about the
neurotoxicity of MB, particularly during
development. Another explanation eliminated
by stereologic assessments is that the number
of TH+ neurons is already reduced by gesta-
tional exposure to MB alone such that PQ
acted to further decrease these numbers,
because no decrease in TH+ neurons was pro-
duced by gestational MB followed by adult
saline exposure (Figure 14). One possibility,
however, is that MB established a “mutant
steady state” (Clarke et al. 2000) in which the
homeostatic state of those cells is abnormal
and confers an increased rate of cell death in
response to a subsequent challenge, a variant
of the multiple-hit model posed in support of
these experiments.
Even in the absence at the present time of
an understanding of the speciﬁc mechanisms
by which such augmentation of adverse effects
can occur across delays of exposure between
treatments, such findings raise serious ques-
tions about the adequacy of current risk assess-
ment paradigms to encompass the patterns of
toxicities observed in these studies. For exam-
ple, the enhancement of the dopaminergic tox-
icity of PQ in adults by previous gestational
exposure to MB would not necessarily have
been predicted in advance; no structural simi-
larities exist between these compounds, and
they do not appear to act by identical mecha-
nisms. Moreover, issues of cumulative toxicity,
repeated insults, and exposures to mixtures are
not addressed explicitly in the derivation of
risk. Certainly, the question must be raised of
whether the simple addition of uncertainty fac-
tors to a no-observed-adverse-effect levels in
the risk assessment context would suffice to
cover the toxicity produced by these sequential
treatments. In addition the possibility that
pharmaceuticals, herbal supplements, or food
additives might interact with pesticides via tox-
icokinetic mechanisms, a phenomenon seen
with MB potentiation of PQ effects, has not
yet received sufﬁcient consideration.
The brain, of course, consists of a complex
network of highly interactive systems. This
interactive matrix may account for the
enhanced vulnerability of the brain under
some conditions of neurotoxic chemical expo-
sure. The occurrence of adverse effects any-
where within such circuits may result in
disturbances across such networks and in asso-
ciated behavioral output. Thus, the brain pro-
vides a more extensive matrix for damage than
is seen in many other organs. In addition,
direct effects at one point in such interactive
systems may be ampliﬁed and produce indirect
damage at other points within the network.
Because different brain systems use common
neurotransmitters for excitatory and inhibitory
function, insults targeting neurotransmitter
function per se, for example, receptors, trans-
porters, or neurotransmitters, can have broad
ramifications across the brain and thereby
inﬂuence a wider array of behavioral functions.
The multiple-hit hypothesis of neuro-
toxicity upon which these studies were based
postulates that insults to different target sites
within a specific brain system, here the
nigrostriatal DA system, when occurring con-
currently or cumulatively, will compromise
homeostatic and repair capacities of the system
and thereby increase its vulnerability. Findings
consistent with our hypothesis, as observed in
these studies, suggest such a biologic plausibil-
ity rationale as a new strategy for defining
potentially signiﬁcant neurotoxic mixtures in a
risk context for future studies, speciﬁcally mix-
tures of neurotoxicants acting on the same sys-
tem of the brain but via different mechanisms
of action.
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